RENASANT CORP (RNST) earnings date, results and what the price requires
NYSE · SEC CIK 0000715072 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 28, 2026 | — | $87.1M | $0.94 | Filing |
| Mar 31, 2026 | Apr 28, 2026 | — | $88.2M | $0.94 | Filing |
| Dec 31, 2025 | Jan 27, 2026 | — | $78.9M | $0.78 | Filing |
| Sep 30, 2025 | Oct 28, 2025 | — | $59.8M | $0.63 | Filing |
| Jun 30, 2025 | Jul 22, 2025 | — | $1.0M | $0.01 | Filing |
| Mar 31, 2025 | Apr 22, 2025 | — | $41.5M | $0.65 | Filing |
| Dec 31, 2024 | Jan 28, 2025 | — | $44.7M | $0.70 | Filing |
| Sep 30, 2024 | Oct 22, 2024 | — | $72.5M | $1.18 | Filing |
What would RENASANT CORP have to report for its valuation to change?
At $39.77, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 0.7% a year, to $3.40. On that path the next quarter needs diluted EPS near $0.63, against $0.63 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 0.7% | 0.7% |
| EPS needed in final year | $3.40 | $3.40 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. RNST goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.